RecruitingNCT06981156

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)


Sponsor

University of Wisconsin, Madison

Enrollment

75 participants

Start Date

May 13, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.


Eligibility

Min Age: 1 YearMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a new neurological assessment tool called pNANO (Neurologic Assessment in Pediatric Neuro-Oncology) to help doctors better track nervous system function in children and teenagers with brain or spine tumors. The goal is to see how well this structured assessment captures changes in neurological status over time. **You may be eligible if...** - You (or your child) are 1 year of age or older - You are seen in a pediatric cancer clinic - You have been diagnosed with a brain or spine tumor, confirmed by imaging or biopsy - You (or your parent/guardian) are able to understand and sign the consent form **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTpNANO Assessment

pNANO assesses patient gait, strength, cerebellar function, visual fields, visual acuity, facial strength, level of consciousness, extraocular movement, dysarthria, and dysphagia The patient will be assessed by 2-3 different clinicians during each of 2 visits.


Locations(1)

American Family Children's Hospital

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06981156


Related Trials